EA201100884A1 - Моноклональные антитела анти-rhd - Google Patents

Моноклональные антитела анти-rhd

Info

Publication number
EA201100884A1
EA201100884A1 EA201100884A EA201100884A EA201100884A1 EA 201100884 A1 EA201100884 A1 EA 201100884A1 EA 201100884 A EA201100884 A EA 201100884A EA 201100884 A EA201100884 A EA 201100884A EA 201100884 A1 EA201100884 A1 EA 201100884A1
Authority
EA
Eurasian Patent Office
Prior art keywords
rhd
monoclonal antibodies
antibodies anti
monoclonal antibody
rhesus
Prior art date
Application number
EA201100884A
Other languages
English (en)
Other versions
EA024722B1 (ru
Inventor
Гаутам Винод Дафтару
Джон Каундиня
Томас Синек
Original Assignee
Бхарат Сирумс Энд Вэксинс Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Бхарат Сирумс Энд Вэксинс Лтд. filed Critical Бхарат Сирумс Энд Вэксинс Лтд.
Publication of EA201100884A1 publication Critical patent/EA201100884A1/ru
Publication of EA024722B1 publication Critical patent/EA024722B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Изобретение относится к получению и применению анти-резус В моноклональных антител и их антигенсвязывающих фрагментов. Кроме того, в изобретении описываются фармацевтические композиции и способы ингибирования и предупреждения иммунизации RhD-отрицательного пациента человека против RhD-положительной крови, в том числе, содержащие применение профилактически эффективного количества моноклонального антитела, и использование такого моноклонального антитела для изготовления лекарственного средства.
EA201100884A 2008-12-31 2009-12-24 МОНОКЛОНАЛЬНЫЕ АНТИТЕЛА АНТИ-RhD EA024722B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2730MU2008 2008-12-31
PCT/IN2009/000741 WO2010079510A2 (en) 2008-12-31 2009-12-24 Anti-rhd monoclonal antibodies

Publications (2)

Publication Number Publication Date
EA201100884A1 true EA201100884A1 (ru) 2012-02-28
EA024722B1 EA024722B1 (ru) 2016-10-31

Family

ID=42316926

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201100884A EA024722B1 (ru) 2008-12-31 2009-12-24 МОНОКЛОНАЛЬНЫЕ АНТИТЕЛА АНТИ-RhD

Country Status (10)

Country Link
US (1) US8529903B2 (ru)
EP (2) EP2450381B1 (ru)
CN (1) CN102272160A (ru)
AU (1) AU2009336567B2 (ru)
CA (1) CA2746350C (ru)
EA (1) EA024722B1 (ru)
EC (1) ECSP11011190A (ru)
ES (2) ES2692173T3 (ru)
MX (1) MX2011006869A (ru)
WO (1) WO2010079510A2 (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2992104B1 (en) * 2013-05-03 2019-04-17 Fujifilm Diosynth Biotechnologies UK Limited Expression process
US20160311918A1 (en) * 2013-12-16 2016-10-27 Texas Tech University System Anti-Ron Monoclonal Antibodies as a Cytotoxic Drug Delivery System for Targeted Cancer Therapy
RU2688627C2 (ru) 2014-03-31 2019-05-22 Университетет И Тромсё - Норгес Арктиске Университет АНТИТЕЛА К HPA-1a
CA2956072A1 (en) * 2014-07-21 2016-01-28 Bloodworks Antibodies that recognize red blood cell antigens
WO2017005923A1 (en) * 2015-07-09 2017-01-12 Institut National De La Sante Et De La Recherche Medicale (Inserm) Lentiviral vector expressing membrane-anchored or secreted antibody
CN114409791B (zh) * 2022-01-26 2023-01-24 南京医科大学 一种全人源抗人红细胞RhD全分子IgG及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8610106D0 (en) 1986-04-25 1986-05-29 Central Blood Lab Authority Human igm-producing heterohybridoma
GB8722018D0 (en) 1987-09-18 1987-10-28 Central Blood Lab Authority Human anti-rh(d)monoclonal antibodies
US6475787B1 (en) 1989-07-28 2002-11-05 Wyeth Method for producing monoclonal antibodies
FR2724182B1 (fr) * 1994-09-02 1996-12-13 Pasteur Institut Obtention d'un anticorps monoclonal recombinant a partir d'un anticorps monoclonal humain anti-rhesus d, sa production en cellules d'insecte, et ses utilisations
FR2807767B1 (fr) 2000-04-12 2005-01-14 Lab Francais Du Fractionnement Anticorps monoclonaux anti-d

Also Published As

Publication number Publication date
US8529903B2 (en) 2013-09-10
ES2692173T3 (es) 2018-11-30
CA2746350A1 (en) 2010-07-15
EP2370469A2 (en) 2011-10-05
EP2370469B1 (en) 2018-09-05
EA024722B1 (ru) 2016-10-31
WO2010079510A3 (en) 2010-10-07
ECSP11011190A (es) 2011-09-30
EP2450381A1 (en) 2012-05-09
CN102272160A (zh) 2011-12-07
AU2009336567A1 (en) 2011-06-30
ES2740051T3 (es) 2020-02-05
EP2450381B1 (en) 2019-07-03
AU2009336567B2 (en) 2014-02-20
CA2746350C (en) 2018-06-12
MX2011006869A (es) 2011-07-19
US20120027769A1 (en) 2012-02-02
WO2010079510A2 (en) 2010-07-15

Similar Documents

Publication Publication Date Title
CY1122245T1 (el) Pd-1 αντισωμα, θραυσμα δεσμευσης αντιγονου αυτου, και ιατρικη εφαρμογη αυτου
UA94452C2 (ru) Гуманизированные моноклональные антитела к фактору роста гепатоцитов
UA109633C2 (uk) Антитіло людини проти тканинного фактора
MX2014001373A (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
IL212633A (en) A monoclonal antibody or its antigen-binding portion, its pharmaceutical preparations and its use in the preparation of cancer drugs
TN2010000210A1 (en) Monoclonal antibodies that bind to hgm-csf and medical compositions comprising same
UA118441C2 (uk) Антитіло, що розпізнає альфа-синуклеїн
UA116194C2 (uk) Антитіло, яке специфічно зв'язується з людським альфа-синуклеїном
MX2014001374A (es) Composicion farmaceutica para el tratamiento y/o prevencion de cancer.
UA90457C2 (ru) Человеческое моноклональное антитело, которое специфически связывается с м-csf человека и блокирует связывание м-csf с с-fms
UA112743C2 (uk) Терапевтичний dll4-зв'язувальний білок
WO2010054265A3 (en) Monoclonal antibodies to fibroblast growth factor receptor 2
UA113623C2 (uk) Моноклональне антитіло проти інгібітору шляху тканинного фактора (tfpi)
UA109658C2 (xx) Антитіло проти cgrp
RU2430111C3 (ru) Молекулы антител с улучшенными свойствами
PE20110771A1 (es) Anticuerpos monoclonales contra el inhibidor de la via del factor tisular (tfpi)
UA115439C2 (uk) Гуманізоване антитіло, яке розпізнає альфа-синуклеїн
EA201100884A1 (ru) Моноклональные антитела анти-rhd
EA201290849A1 (ru) Оптимизированные моноклональные антитела против ингибитора пути тканевого фактора (tfpi)
RU2011142183A (ru) Средство для лечения ревматоидного артрита
DOP2013000113A (es) Proteínas de unión a antígenos
MX2018007925A (es) Anticuerpo pcsk9, fragmento de union al antigeno y aplicacion medica del mismo.
GT201300058A (es) Composiciones de anticuerpos anti-vegfr-3
IL213213A (en) Use of Human Monoclonal Antibodies or Antigen-Related Fragments Specific to Human Ligand Protein Protein in the Manufacture of Medicines to Prevent and / or Treat Pampigos
EA202192776A1 (ru) Схемы введения доз и композиции, включающие антитела к rsv

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM